MedPath

Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis

Completed
Conditions
Psychotic Disorders
Registration Number
NCT01688765
Lead Sponsor
Mclean Hospital
Brief Summary

The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.

Detailed Description

The purpose of this study is to investigate the structural, functional and chemical brain abnormalities in patients with first episode psychosis and assess the evolution of these abnormalities during the course of the disease.

The study design is case-control, there are no interventions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
187
Inclusion Criteria
  • Clinical diagnosis of first episode of a psychotic disorder
  • Healthy controls with no psychiatric disorder history
Exclusion Criteria
  • Significant neurological or medical illness history
  • Ages <18 or >45

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

McLean Hospital

πŸ‡ΊπŸ‡Έ

Belmont, Massachusetts, United States

McLean Hospital
πŸ‡ΊπŸ‡ΈBelmont, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.